- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04256460
Shanghai Community Prediabetes Standardized Management Project
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants with prediabetes is the key targets for diabetes prevention. So, in order to further strengthen and standardize the management of participants with prediabetes in the communities, the investigators start this project of standardized management of participants with prediabetes in communities of Shanghai. Explore the standardized management model for prediabetes participants within primary healthcare settings in Shanghai, to reduce the risk factors of diabetes, improve the blood glucose control, and the quality of life of participants with prediabetes.
Through the collaboration the Shanghai Municipal Center for Disease Control & Prevention network, this investigators will implement prediabetes screening and lifestyle intervention in around 50 community health service centers in Shanghai. Life-style interventions including exercise and diet, and diabetes prevention knowledge will be integrated into "train-the-trainers" workshops. Trainings will be provided to community health service staff and peer supporters or social workers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China
- Anting community health service center
-
Shanghai, Shanghai, China
- Baihe community health service center
-
Shanghai, Shanghai, China
- Beiwaitan community health service center
-
Shanghai, Shanghai, China
- Caoyang community health service center
-
Shanghai, Shanghai, China
- Changfeng baiyu community health service center
-
Shanghai, Shanghai, China
- Changfeng changfeng community health service center
-
Shanghai, Shanghai, China
- Changqiao community health service center
-
Shanghai, Shanghai, China
- Changshou community health service center
-
Shanghai, Shanghai, China
- Changzhengzhen community health service center
-
Shanghai, Shanghai, China
- Chendun community health service center
-
Shanghai, Shanghai, China
- Chonggu community health service center
-
Shanghai, Shanghai, China
- Dahua community health service center
-
Shanghai, Shanghai, China
- Dongjing community health service center
-
Shanghai, Shanghai, China
- Fangsong community health service center
-
Shanghai, Shanghai, China
- Fenglin community health service center
-
Shanghai, Shanghai, China
- Ganquan community health service center
-
Shanghai, Shanghai, China
- Hongmei community health service center
-
Shanghai, Shanghai, China
- Huamu community health service center
-
Shanghai, Shanghai, China
- Huangdu community health service center
-
Shanghai, Shanghai, China
- Huinan community health service center
-
Shanghai, Shanghai, China
- Jiangwan community health service center
-
Shanghai, Shanghai, China
- Jinqiao community health service center
-
Shanghai, Shanghai, China
- Jinyang community health service center
-
Shanghai, Shanghai, China
- Juyuanxinqu community health service center
-
Shanghai, Shanghai, China
- Kangjian community health service center
-
Shanghai, Shanghai, China
- Liantang community health service center
-
Shanghai, Shanghai, China
- Longhua community health service center
-
Shanghai, Shanghai, China
- Luodian community health service center
-
Shanghai, Shanghai, China
- Luojing community health service center
-
Shanghai, Shanghai, China
- Malu community health service center
-
Shanghai, Shanghai, China
- Miaohang community health service center
-
Shanghai, Shanghai, China
- Nanjingxi Road community health service center
-
Shanghai, Shanghai, China
- Nanxiang community health service center
-
Shanghai, Shanghai, China
- Nicheng community health service center
-
Shanghai, Shanghai, China
- Puxing community health service center
-
Shanghai, Shanghai, China
- Qilian community health service center
-
Shanghai, Shanghai, China
- Quyang community health service center
-
Shanghai, Shanghai, China
- Sheshan community health service center
-
Shanghai, Shanghai, China
- Shiquan community health service center
-
Shanghai, Shanghai, China
- Songnan community health service center
-
Shanghai, Shanghai, China
- Tangzhen community health service center
-
Shanghai, Shanghai, China
- Taopuzhen community health service center
-
Shanghai, Shanghai, China
- Taopuzhen No.2 community health service center
-
Shanghai, Shanghai, China
- Tianlin community health service center
-
Shanghai, Shanghai, China
- Waigang community health service center
-
Shanghai, Shanghai, China
- Xianghuaqiao community health service center
-
Shanghai, Shanghai, China
- Xiaokunshan community health service center
-
Shanghai, Shanghai, China
- Yichuan community health service center
-
Shanghai, Shanghai, China
- Yuepu community health service center
-
Shanghai, Shanghai, China
- Zhaoxiang community health service center
-
Shanghai, Shanghai, China
- Zhenruzhen community health service center
-
Shanghai, Shanghai, China
- Zhongshan community health service center
-
Shanghai, Shanghai, China
- Zhujiajiao community health service center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chinese residents
- Adult age ≥ 18 years old, 35-75 years old preferred
- Participants receiving prediabetes management of the basic public health services package in community health centers
- BMI≥24 kg/m2 or central obesity (Waist circumference≥90 cm in males,Waist circumference≥85 cm in females) or Hypertension (SBP≥140 mmHg and/or DBP≥90 mmHg) preferred
- Signed informed consents and willing to participate
Exclusion Criteria:
- With serious chronic diseases, tumors, acute and chronic infectious diseases, limb movement disorders, and any mental illnesses
- Women during pregnancy or breastfeeding
- With excessive drinking or illicit drug use
- Unwilling to participate in the project
- Histories of severe cardiovascular events (myocardial infarction, stroke, acute coronary syndrome, or transient ischemic attack (TIA))
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention arm
Behavior intervention including health education on diet, exercises and self management support through peer support, and also receive regular care and follow up in community health centers
|
After assessing the exercise and nutritional status of the participants, health staff in community health centers implemented personalized healthy diet and regular exercises intervention, including coaching on healthy exercises and developing personalized dietary prescriptions for participants.
Besides, peer support is implemented as a self management strategy in community health service centers or community self management groups to enhance the behavioral change support for these participants.
|
NO_INTERVENTION: Control arm
Receiving regular care and follow up in Community health centers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of BMI from baseline at 12 months
Time Frame: Baseline, 12 months
|
body mass index, using the examination results of height (cm) and weight (kg)
|
Baseline, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of HbA1c from baseline at 12 months
Time Frame: Baseline, 12 months
|
hemoglobin A1c (%)
|
Baseline, 12 months
|
Change of Waist circumference from baseline at 12 months
Time Frame: Baseline, 12 months
|
Waist circumference (cm)
|
Baseline, 12 months
|
Change of Fasting Plasma Glucose from baseline at 12 months
Time Frame: Baseline, 12 months
|
fasting plasma glucose (mmol/L)
|
Baseline, 12 months
|
Change of Blood Pressure from baseline at 12 months
Time Frame: Baseline, 12 months
|
Blood pressure including systolic blood pressure and diastolic blood pressure (mmHg)
|
Baseline, 12 months
|
Change of Total Cholesterol from baseline at 12 months
Time Frame: Baseline, 12 months
|
total cholesterol (mmol/L)
|
Baseline, 12 months
|
Change of Triglyceride from baseline at 12 months
Time Frame: Baseline, 12 months
|
Triglyceride (mmol/L)
|
Baseline, 12 months
|
Change of High density lipoprotein cholesterol from baseline at 12 months
Time Frame: Baseline, 12 months
|
High density lipoprotein-Cholesterol (mmol/L)
|
Baseline, 12 months
|
Change of Low density lipoprotein cholesterol from baseline at 12 months
Time Frame: Baseline, 12 months
|
Low density lipoprotein-Cholesterol (mmol/L)
|
Baseline, 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Liver Functioning from baseline at 12 months
Time Frame: Baseline, 12 months
|
alanine transaminase (U/L), Aspartate transaminase (U/L), Alkaline phosphatase (U/L), glutamyltransferase (U/L)
|
Baseline, 12 months
|
Change of Urine Albumin/Creatinine Ratio from baseline at 12 months
Time Frame: Baseline, 12 months
|
Albumin (mg/L), Creatinine (mmol/L)
|
Baseline, 12 months
|
Change of Bilirubin from baseline at 12 months
Time Frame: Baseline, 12 months
|
Total bilirubin (μmol/L), Direct bilirubin (μmol/L) Total bilirubin (μmol/L), Direct bilirubin (μmol/L) |
Baseline, 12 months
|
Change of Blood Urea from baseline at 12 months
Time Frame: Baseline, 12 months
|
Blood urea (mmol/L)
|
Baseline, 12 months
|
Change of Serum Creatinine from baseline at 12 months
Time Frame: Baseline, 12 months
|
Serum creatinine (μmol/L)
|
Baseline, 12 months
|
Change of Uric Acid from baseline at 12 months
Time Frame: Baseline, 12 months
|
Uric acid (μmol/L)
|
Baseline, 12 months
|
Change of oral glucose tolerance test-2 hour from baseline at 12 months
Time Frame: Baseline, 12 months
|
oral glucose tolerance test-2 hour (mmol/L)
|
Baseline, 12 months
|
Change of Diabetes Self Care Behaviors from baseline at 12 months
Time Frame: Baseline, 12 months
|
9 items from Summary of Diabetes Self Care Activities and Behavioral Risk Factor Surveillance System.
Items 1-7 measure diabetes self care activities during the previous 7 days.
Items 1, 2, 4-7 are assessed on a scale of 0 to 7 days.
Item 3 is assessed on scale of 1-4, where 1 represents very low levels of daily activity and 4 represents very high levels of daily activity.
Items 8 and 9 are yes/no questions that measure cigarette intake over the past 7 and 30 days.
|
Baseline, 12 months
|
Change of General Quality of Life from baseline at 12 months
Time Frame: Baseline, 12 months
|
6-item Euro quality-of-life-5D, a standardized instrument for measuring generic health status.
The respondents are asked to choose one of the statements which best describes their health status on the surveyed day.
Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3.
As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).
Item 6 is the visual analogue scale, in which respondents are asked to mark their health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100, where 0 corresponds to "the worst health you can imagine", and 100 corresponds to "the best health you can imagine"
|
Baseline, 12 months
|
Change of Diabetes Quality of Life from baseline at 12 months
Time Frame: Baseline, 12 months
|
4-item Diabetes Distress Scale, an abbreviated version of the 17-item Diabetes Distress Scale.
The respondents are asked to respond to which degree each of the items has bothered them in the past month on a 6-point scale (1-6), where 1 is not a brother and 6 is very bothersome.
Scores are summed and divided by 4 to calculate the mean.
Mean scores of 3 or higher (moderate distress) are considered worthy of clinical attention.
|
Baseline, 12 months
|
Change of Depression from baseline at 12 months
Time Frame: Baseline, 12 months
|
8-item Patient Health Questionnaire (PHQ), the PHQ-9 minus the last question on suicidal thoughts.
The PHQ is a standard instrument used in primary care settings to screen for the presence and severity of depression.
The respondents are asked how often they have been bothered by each of the 8 items in the past 2 weeks on a 4 point scale (0-3), where 0 is "not all" and 3 is "nearly every day".
The scores for each item are summed to produce a total score between 0 and 24 points.
A total score of 0 to 4 represents no significant depressive symptoms.
A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.
|
Baseline, 12 months
|
Change of Insulin Attitudes from baseline at 12 months
Time Frame: Baseline, 12 months
|
6 questions
|
Baseline, 12 months
|
Change of Neighborhood Interactions from baseline at 12 months
Time Frame: Baseline, 12 months
|
6 questions
|
Baseline, 12 months
|
Change of Peer Support Engagement and Health Care Utilization from baseline at 12 months
Time Frame: Baseline, 12 months
|
5 questions
|
Baseline, 12 months
|
Change of General information and risk factors questionnaire from baseline at 12 months
Time Frame: Baseline, 12 months
|
Demographic questions, medical histories, risk factors including family history, smoking, alcohol drinking, diet, and exercises, medication information and adherence.
|
Baseline, 12 months
|
Change of C-reaction protein from baseline at 12 months
Time Frame: Baseline, 12 months
|
C-reaction protein
|
Baseline, 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Shanghai6
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
TNOWageningen University and Research; Google LLC.; Jumbo Supermarkten Bv.; Noldus...Completed
-
University of TorontoInternational Nut and Dried Fruit Council (INC); The National Dried Fruit Trade... and other collaboratorsUnknown
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
Clinical Trials on Healthy diet, regular exercises and peer support
-
Grupo LusófonaUniversity of Lisbon; Fundação para a Ciência e a TecnologiaCompletedObesity | Physical Activity | Sedentary LifestylePortugal
-
Cukurova UniversityCompletedAnxiety | Sleep DisturbanceTurkey
-
University College, LondonUniversity College London HospitalsRecruitingObesity | Overweight | Cardiometabolic SyndromeUnited Kingdom
-
Bezmialem Vakif UniversityRecruitingOverweight | ExerciseTurkey
-
University of OuluRecruitingSarcopenia | Colon CancerFinland
-
Dartmouth-Hitchcock Medical CenterHarvard University; VinfenCompletedCardiovascular Diseases | Smoking | Obesity | Diabetes | Schizophrenia | Bipolar Disorder | Blood Pressure Disorders | Cholesterol, Elevated | Major Depressive Disorder, RecurrentUnited States
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
Johns Hopkins UniversityCompleted
-
Istanbul UniversityIstanbul University - Cerrahpasa (IUC)RecruitingRespiration Disorders | Obesity | Sleep Disorder | Hypoventilation | Obesity Hypoventilation Syndrome (OHS)Turkey
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Human Sciences Research CouncilCompletedTuberculosis | Human Immunodeficiency Virus | Acquired Immune Deficiency SyndromeSouth Africa